ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,604 | -9.1% | 138,683 | 0.0% | 0.01% | 0.0% |
Q1 2024 | $3,966 | -4.5% | 138,683 | +2.1% | 0.01% | -11.1% |
Q4 2023 | $4,155 | +13.8% | 135,783 | -0.1% | 0.01% | 0.0% |
Q3 2023 | $3,651 | -24.8% | 135,883 | -0.2% | 0.01% | -18.2% |
Q2 2023 | $4,856 | +39.5% | 136,183 | -0.7% | 0.01% | +37.5% |
Q1 2023 | $3,482 | -37.3% | 137,083 | +0.1% | 0.01% | -42.9% |
Q4 2022 | $5,556 | -99.9% | 136,983 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $4,527,000 | -5.9% | 136,983 | +0.2% | 0.01% | 0.0% |
Q2 2022 | $4,813,000 | -23.2% | 136,683 | +0.4% | 0.01% | -7.7% |
Q1 2022 | $6,263,000 | -30.5% | 136,183 | +0.1% | 0.01% | -23.5% |
Q4 2021 | $9,016,000 | +16.6% | 135,983 | +9.8% | 0.02% | +6.2% |
Q3 2021 | $7,733,000 | -21.8% | 123,864 | +3.8% | 0.02% | -23.8% |
Q2 2021 | $9,886,000 | +15.6% | 119,372 | -7.4% | 0.02% | +16.7% |
Q1 2021 | $8,552,000 | -19.2% | 128,972 | -6.5% | 0.02% | -21.7% |
Q4 2020 | $10,587,000 | +74.4% | 137,972 | -2.1% | 0.02% | +53.3% |
Q3 2020 | $6,070,000 | -0.9% | 140,972 | -0.6% | 0.02% | 0.0% |
Q2 2020 | $6,123,000 | +70.2% | 141,772 | +13.4% | 0.02% | +36.4% |
Q1 2020 | $3,598,000 | -53.0% | 125,072 | +3.6% | 0.01% | -38.9% |
Q4 2019 | $7,661,000 | +98.2% | 120,772 | -12.0% | 0.02% | +80.0% |
Q3 2019 | $3,865,000 | +257.9% | 137,166 | +236.5% | 0.01% | +233.3% |
Q2 2019 | $1,080,000 | – | 40,766 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |